SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (5397)9/25/1998 4:51:00 PM
From: Izzy  Read Replies (1) of 6136
 
Steve, Viracept is available in 250 mg tabs (#250/bottle; wholesale cost of $560). Therefore, wholesale ("Red Book") price is $2.07/tab with an approx retail price of $2.40/tab (prices may vary in different areas of the country/world). Therefore, 3 tabs TID = 9/day = $18.63 (pharmacy cost) = $21.60 (approx retail cost). 5 tabs (1250 mg) BID = 10/day = $20.70 (pharmacy cost) = $24.07 (approx retail cost). The Viracept powder (pediatric use) costs $60 for 144 gms (5 ounces); ? dosage (I don't treat children). With the BID schedule, the annual cost would be approx $8785 and, for the TID schedule, annual cost is approx $7885. Actually, there's not that much "markup" in price compared to other medications, and, considering ancillary pharmacy costs (eg., pharmacist's salary, overhead), there's really not that much profit being made, IMO. PS: Hope I did the math correctly. Tried to quickly answer your query (sorry, didn't see it earlier).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext